Publications by authors named "Angus Robinson"

Claim this Profile
U
UK real-world data of radium-223 dichloride in metastatic prostate cancer.
Manreet Randhawa, Gail Buchanan, Irene M Stratton, Gemma Race, Amar Challapalli, Angus Robinson

Nucl Med Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.
Martin J Connor, Mesfin Genie, Tim Dudderidge, Hangjian Wu, Johanna Sukumar, Angus Robinson

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate-Resistant Prostate Cancer (TRICREST).
Kenrick Ng, Garima Priyadarshini, Shah-Jalal Sarker, Angus Robinson, Neil McPhail

Prostate· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Gerhardt Attard, Laura Murphy, Noel W Clarke, Ashwin Sachdeva, Craig Jones, Angus Robinson

Lancet Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Nicholas D James, Noel W Clarke, Adrian Cook, Adnan Ali, Alex P Hoyle, Angus J Robinson

Int J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
David Dearnaley, Victoria Hinder, Adham Hijab, Gail Horan, Narayanan Srihari, Angus Robinson

Lancet Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE.
Heather Payne, Angus Robinson, Bernard Rappe, Serena Hilman, Ugo De Giorgi

Int J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Gerhardt Attard, Laura Murphy, Noel W Clarke, William Cross, Robert J Jones, Angus Robinson

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study.
Martin John Connor, Mesfin G Genie, Michael Gonzalez, Naveed Sarwar, Kamalram Thippu Jayaprakash, Angus Robinson

BMJ Open· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis.
Michael Ager, Kelechi Njoku, Maria Serra, Angus Robinson, Lisa Pickering

BJU Int· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Ruth E Langley, Duncan C Gilbert, Trinh Duong, Noel W Clarke, Matthew Nankivell, Angus Robinson

Lancet· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID).
Simon J Crabb, Gareth Griffiths, Ellice Marwood, Denise Dunkley, Nichola Downs, Angus Robinson

J Clin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Joaquin Mateo, Nuria Porta, Diletta Bianchini, Ursula McGovern, Tony Elliott, Angus Robinson

Lancet Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice.
Sabina Dizdarevic, Maryam Jessop, Patrick Begley, Sean Main, Angus Robinson

Eur J Nucl Med Mol Imaging· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Beth S Woods, Eleftherios Sideris, Matthew R Sydes, Melissa R Gannon, Mahesh K B Parmar, Angus Robinson

Eur Urol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Nicholas D James, Johann S de Bono, Melissa R Spears, Noel W Clarke, Malcolm D Mason, Angus Robinson

N Engl J Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.
Thomas Powles, Matthew Wheater, Omar Din, Thomas Geldart, Ekaterini Boleti, Angus Robinson

Eur Urol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Nicholas D James, Matthew R Sydes, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Angus J Robinson

Lancet· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Gary Middleton, Paul Silcocks, Trevor Cox, Juan Valle, Jonathan Wadsley, Angus Robinson

Lancet Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infections and cancer in Uganda.
Angus Robinson, Edward Katongale-Mbidde

Lancet· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis